These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 23746118

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.
    Yankol Y, Bugeaud E, Zens T, Rizzari M, Mecit N, Leverson GE, Foley D, Mezrich JD, Kanmaz T, Andaçoğlu OM, D'Alessandro AM, Acarlı KS, Kalayoğlu M, Fernandez LA.
    Turk J Med Sci; 2021 Apr 30; 51(2):610-622. PubMed ID: 33037873
    [Abstract] [Full Text] [Related]

  • 24. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM, Smith AR, Abecassis M, Baker T, Emond JC, Berg CL, Beil CA, Burton JR, Fisher RA, Freise CE, Gillespie BW, Grant DR, Humar A, Kam I, Merion RM, Pomfret EA, Samstein B, Shaked A.
    Ann Surg; 2015 Sep 30; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012.
    Hoehn RS, Wilson GC, Wima K, Hohmann SF, Midura EF, Woodle ES, Abbott DE, Singhal A, Shah SA.
    Liver Transpl; 2014 Nov 30; 20(11):1347-55. PubMed ID: 25044564
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparable short- and long-term outcomes in deceased-donor and living-donor liver retransplantation.
    Chok KSH, Chan ACY, Fung JYY, Dai WC, Cheung TT, Lo CM.
    Hepatol Int; 2017 Nov 30; 11(6):517-522. PubMed ID: 28936686
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS, Baker TB, Everson GT, Hong JC, Terrault N, Hayashi PH, Fisher RA, Everhart JE.
    Hepatology; 2011 Oct 30; 54(4):1313-21. PubMed ID: 21688284
    [Abstract] [Full Text] [Related]

  • 31. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A, Ganesh S, Jorgensen D, Tevar A, Ganoza A, Molinari M, Hughes C.
    Ann Surg; 2019 Sep 30; 270(3):444-451. PubMed ID: 31305283
    [Abstract] [Full Text] [Related]

  • 32. More than a quarter of a century of liver transplantation in Kaohsiung Chang Gung Memorial Hospital.
    Chen CL, Concejero AM, Cheng YF.
    Clin Transpl; 2011 Sep 30; ():213-21. PubMed ID: 22755415
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients.
    Shen B, Chen B, Zhang W, Mao H, Shen C, Deng X, Zhan X, Chen H.
    Liver Transpl; 2009 Nov 30; 15(11):1473-80. PubMed ID: 19877254
    [Abstract] [Full Text] [Related]

  • 35. Live donor liver transplantation in high MELD score recipients.
    Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.
    Ann Surg; 2010 Jan 30; 251(1):153-7. PubMed ID: 19858705
    [Abstract] [Full Text] [Related]

  • 36. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.
    Li C, Mi K, Wen Tf, Yan Ln, Li B, Yang Jy, Xu Mq, Wang Wt, Wei Yg.
    PLoS One; 2011 Jan 30; 6(11):e27366. PubMed ID: 22087299
    [Abstract] [Full Text] [Related]

  • 37. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation.
    Gómez CM, Dumonceau JM, Marcolongo M, de Santibañes E, Ciardullo M, Pekolj J, Palavecino M, Gadano A, Dávolos J.
    Transplantation; 2009 Dec 15; 88(11):1280-5. PubMed ID: 19996927
    [Abstract] [Full Text] [Related]

  • 38. Results of pediatric living donor compared to deceased donor liver transplantation in the PELD/MELD era: Experience from two centers on two different continents.
    Yankol Y, Fernandez LA, Kanmaz T, Leverson GE, Mezrich JD, Foley D, Mecit N, D'Alessandro AM, Acarli K, Kalayoglu M.
    Pediatr Transplant; 2016 Feb 15; 20(1):72-82. PubMed ID: 26861217
    [Abstract] [Full Text] [Related]

  • 39. A multicenter study of 30 days complications after deceased donor liver transplantation in the model for end-stage liver disease score era.
    Parikh A, Washburn KW, Matsuoka L, Pandit U, Kim JE, Almeda J, Mora-Esteves C, Halff G, Genyk Y, Holland B, Wilson DJ, Sher L, Koneru B.
    Liver Transpl; 2015 Sep 15; 21(9):1160-8. PubMed ID: 25991395
    [Abstract] [Full Text] [Related]

  • 40. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M, Abaalkhail F, Hashim A, Al Bahili H, Alabbad S, Shoukdy M, Elsiesy H.
    Transplant Proc; 2015 May 15; 47(4):1211-3. PubMed ID: 26036556
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.